CD7-positive leukemic blasts with DNMT3A mutations predict poor prognosis in patients with acute myeloid leukemia

CD7-positive leukemic blasts with DNMT3A mutations predict poor prognosis in patients with acute myeloid leukemia

BackgroundDNMT3A mutations can be detected in premalignant hematopoietic stem cells and are primarily associated with clonal hematopoiesis of indeterminate potential; however, current evidence does not support assigning them to a distinct European Leukemia Net (ELN) prognostic risk stratification. C...

Full description

Bibliographic Details
Main Authors:	Yanliang Bai, Xiaobai Sun, Mengyi Li, Xiaona Niu, Weijie Cao, Junwei Niu, Xingjun Xiao, Yuqing Chen, Kai Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Oncology
Subjects:	acute myeloid leukemia CD7 Dnmt3a immunophenotype molecular diagnostics prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1342998/full

Similar Items

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia
by: Kateřina Kuželová, et al.
Published: (2022-12-01)

Landscape of biallelic DNMT3A mutant myeloid neoplasms
by: Naomi Kawashima, et al.
Published: (2024-09-01)

DNMT3A and TET2 in the pre-leukemic phase of hematopoietic disorders
by: Hanae Sato, et al.
Published: (2016-08-01)

Cleaved Leukemic Blast Cells, Vacuolation, and Pseudopodialike Cytoplasmic Projections in Acute Myeloid Leukemia with TLS: : ERG
by: Xingqin Huang, et al.
Published: (2024-09-01)

Case report: biallelic DNMT3A mutations in acute myeloid leukemia
by: Cosimo Cumbo, et al.
Published: (2023-06-01)

Acute myeloid leukemia: Comparing French–American–British classification with immunophenotype and cytogenetics
by: Mekhala Rao, et al.
Published: (2022-01-01)

Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication
by: Ahmed Mahmoud Taha Khattab, et al.
Published: (2024-09-01)

The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia
by: Xian Chen, et al.
Published: (2023-05-01)

CD117 expression on blast cells in acute myeloid leukemia
by: Goryainova N.V., et al.
Published: (2015-09-01)

CD117 expression on blast cells in acute myeloid leukemia.
by: N. V. Goryainova, et al.
Published: (2015-09-01)

Is Flow Cytometric Immunophenotyping Useful for Predicting Acute Myeloid Leukemia Prognosis?
by: Hava Üsküdar Teke, et al.
Published: (2017-12-01)

Prognostic Significance of Flow Cytometric Immunophenotyping in Patients with Acute Myeloid Leukemia
by: Sinan DEMİRCİOĞLU, et al.
Published: (2022-08-01)

Inmunofenotipaje celular en el diagnostico de la leucemia mieloide aguda Cellular immunophenotyping in the diagnosis of acute myeloid leukemia
Published: (2005-12-01)

Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia
by: Flávia Melo Cunha de Pinho Pessoa, et al.
Published: (2023-04-01)

The Impact of DNMT3A/FLT3-ITD/NPM1 on Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
by: Long Su
Published: (2019-02-01)

DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells
by: Weijing Li, et al.
Published: (2023-03-01)

Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomes
by: Zangbéwendé Guy Ouedraogo, et al.
Published: (2022-05-01)

Aberrant Phenotypes in Acute Myeloid Leukemia and Its Relationship with Prognosis and Survival: A Systematic Review and Meta-Analysis
by: Lucio Henrique Sousa Pinheiro, et al.
Published: (2020-10-01)

RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with <i>DNMT3A</i> Mutations
by: Olga Alexandra Sidorova, et al.
Published: (2022-03-01)

Lens development requires DNMT1 but takes place normally in the absence of both DNMT3A and DNMT3B activity
by: Thanh V. Hoang, et al.
Published: (2017-01-01)

Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: Report of an unusual case
by: Khaliqur Rahman, et al.
Published: (2013-01-01)

Acute Pure Erythroid Leukemia Presenting with Chloroma in a Child: A Case Report with Review of Literature
by: Sudipto Bhattacharya, et al.
Published: (2024-11-01)

Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
by: Xiao-Qing Yuan, et al.
Published: (2019-07-01)

Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia
by: Abdulrhman S. Elbnnani, et al.
Published: (2024-12-01)

Pediatric chronic myeloid leukemia in myeloid blast crisis
by: Biswajit Dey, et al.
Published: (2023-04-01)

The ‘de novo’ DNA methyltransferase Dnmt3b compensates the Dnmt1-deficient intestinal epithelium
by: Ellen N Elliott, et al.
Published: (2016-01-01)

Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy
by: Ting Chen, et al.
Published: (2024-09-01)

DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy
by: Xiaxia Man, et al.
Published: (2022-05-01)

CD56briCD38+ as a novel neutrophil-specific marker in chronic myeloid leukemia
by: Panpan Huang, et al.
Published: (2024-11-01)

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
by: Era L. Pogosova-Agadjanyan, et al.
Published: (2023-03-01)

Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
by: Xingjian Zhai, et al.
Published: (2022-07-01)

Clinical Case of Mild Tatton–Brown–Rahman Syndrome Caused by a Nonsense Variant in <i>DNMT3A</i> Gene
by: Fatima Bostanova, et al.
Published: (2024-05-01)

A case report of complete remission of acute myeloid leukemia combined with DNMT3A, FLT3-TKD, and IDH2 gene mutations and active pulmonary tuberculosis treated with homeharringtonine + venetoclax + azacytidine
by: Lin Ji, et al.
Published: (2023-06-01)

Germline DNMT3A mutation in familial acute myeloid leukaemia
by: Courtney D. DiNardo, et al.
Published: (2021-05-01)

Relationship between Promoter Hypermethylation of DNMT3A and DNMT3B genes and Endometrial Cancer
by: Masoumeh Omidali, et al.
Published: (2019-02-01)

FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
by: Majid Teremmahi Ardestani, et al.
Published: (2018-08-01)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
by: Tianqi Liang, et al.
Published: (2022-12-01)

Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy
by: Dongchan Kim, et al.
Published: (2024-04-01)

DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma
by: Simona Camero, et al.
Published: (2021-10-01)

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells
by: Javier Rodríguez-Ubreva, et al.
Published: (2017-10-01)